BDBM50263018 (1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-2-p-tolyl-1H-imidazol-4-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone::CHEMBL476519

SMILES Cc1ccc(cc1)-c1nc(cn1-c1cccc2OCCOc12)C(=O)N1CCN(CC1)c1ccc2ccccc2c1

InChI Key InChIKey=PJXUJOWRGMSQHK-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50263018   

TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263018((1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-2-p-tolyl...)
Affinity DataEC50:  471nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263018((1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-2-p-tolyl...)
Affinity DataIC50: 140nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed